Literature DB >> 17689697

Deletion of CCR2 but not CCR5 or CXCR3 inhibits aortic aneurysm formation.

Jason Neal MacTaggart1, Wanfen Xiong, Rebecca Knispel, Bernard T Baxter.   

Abstract

BACKGROUND: Microscopic analysis of abdominal aortic aneurysms (AAAs) demonstrates an abundance of infiltrating leukocytes. The chemokine receptors CCR2, CCR5, and CXCR3 are associated with pathways implicated previously in aneurysm pathogenesis. We hypothesized that genetic deletions of CCR2, CCR5, and CXCR3 would limit leukocyte infiltration and aneurysm formation in a mouse model of AAA.
METHODS: CCR2(-/-), CCR5(-/-), CXCR3(-/-), and control mice of the same genetic background were subject to periaortic application of calcium chloride. Aortic diameters were measured before aneurysm induction and at harvest 6 weeks later. Diameters were compared using the Mann-Whitney test. Aortas were stained with H&E and trichrome for histologic analysis. Aortic MMP-2 and MMP-9 activities were measured using zymography.
RESULTS: Aneurysm formation was attenuated in CCR2(-/-) mice with the final mean aortic diameter less than that of the control mice (P < .01). Histology revealed preservation of the lamellar architecture and decreased inflammatory cells. Aortic MMP-2 and MMP-9 levels were decreased in CCR2(-/-) mice. CCR5(-/-) and CXCR3(-/-) mice demonstrated no protection from aneurysm formation, which was corroborated by the tissue histology showing similar inflammatory cell infiltration and elastin degradation.
CONCLUSIONS: The CCR2 receptor is involved directly in AAA formation, whereas the CCR5 and CXCR3 receptors are not.

Entities:  

Mesh:

Substances:

Year:  2007        PMID: 17689697     DOI: 10.1016/j.surg.2007.04.017

Source DB:  PubMed          Journal:  Surgery        ISSN: 0039-6060            Impact factor:   3.982


  30 in total

Review 1.  Monocytes and macrophages in abdominal aortic aneurysm.

Authors:  Juliette Raffort; Fabien Lareyre; Marc Clément; Réda Hassen-Khodja; Giulia Chinetti; Ziad Mallat
Journal:  Nat Rev Cardiol       Date:  2017-04-13       Impact factor: 32.419

2.  CCR2 Positron Emission Tomography for the Assessment of Abdominal Aortic Aneurysm Inflammation and Rupture Prediction.

Authors:  Sean J English; Sergio E Sastriques; Lisa Detering; Deborah Sultan; Hannah Luehmann; Batool Arif; Gyu Seong Heo; Xiaohui Zhang; Richard Laforest; Jie Zheng; Chieh-Yu Lin; Robert J Gropler; Yongjian Liu
Journal:  Circ Cardiovasc Imaging       Date:  2020-03-13       Impact factor: 7.792

3.  Andrographolide Ameliorates Abdominal Aortic Aneurysm Progression by Inhibiting Inflammatory Cell Infiltration through Downregulation of Cytokine and Integrin Expression.

Authors:  Jun Ren; Zhenjie Liu; Qiwei Wang; Jasmine Giles; Jason Greenberg; Nader Sheibani; K Craig Kent; Bo Liu
Journal:  J Pharmacol Exp Ther       Date:  2015-10-19       Impact factor: 4.030

4.  Circulating interferon-γ-inducible Cys-X-Cys chemokine receptor 3 ligands are elevated in humans with aortic aneurysms and Cys-X-Cys chemokine receptor 3 is necessary for aneurysm formation in mice.

Authors:  Amy Gallo; Ahmad Saad; Rahmat Ali; Alan Dardik; George Tellides; Arnar Geirsson
Journal:  J Thorac Cardiovasc Surg       Date:  2011-09-29       Impact factor: 5.209

5.  Elevated protein kinase C-δ contributes to aneurysm pathogenesis through stimulation of apoptosis and inflammatory signaling.

Authors:  Stephanie Morgan; Dai Yamanouchi; Calvin Harberg; Qiwei Wang; Melissa Keller; Yi Si; William Burlingham; Stephen Seedial; Justin Lengfeld; Bo Liu
Journal:  Arterioscler Thromb Vasc Biol       Date:  2012-08-09       Impact factor: 8.311

6.  Inhibition or deletion of angiotensin II type 1 receptor suppresses elastase-induced experimental abdominal aortic aneurysms.

Authors:  Haojun Xuan; Baohui Xu; Wei Wang; Hiroki Tanaka; Naoki Fujimura; Masaaki Miyata; Sara A Michie; Ronald L Dalman
Journal:  J Vasc Surg       Date:  2017-04-20       Impact factor: 4.268

7.  An adventitial IL-6/MCP1 amplification loop accelerates macrophage-mediated vascular inflammation leading to aortic dissection in mice.

Authors:  Brian C Tieu; Chang Lee; Hong Sun; Wanda Lejeune; Adrian Recinos; Xiaoxi Ju; Heidi Spratt; Dong-Chuan Guo; Dianna Milewicz; Ronald G Tilton; Allan R Brasier
Journal:  J Clin Invest       Date:  2009-11-16       Impact factor: 14.808

8.  Peptide inhibitor of CXCL4-CCL5 heterodimer formation, MKEY, inhibits experimental aortic aneurysm initiation and progression.

Authors:  Yasunori Iida; Baohui Xu; Haojun Xuan; Keith J Glover; Hiroki Tanaka; Xiaolei Hu; Naoki Fujimura; Wei Wang; Joshua R Schultz; Court R Turner; Ronald L Dalman
Journal:  Arterioscler Thromb Vasc Biol       Date:  2013-01-03       Impact factor: 8.311

Review 9.  Novel mechanisms of abdominal aortic aneurysms.

Authors:  Hong Lu; Debra L Rateri; Dennis Bruemmer; Lisa A Cassis; Alan Daugherty
Journal:  Curr Atheroscler Rep       Date:  2012-10       Impact factor: 5.113

10.  Interferon-gamma and the interferon-inducible chemokine CXCL10 protect against aneurysm formation and rupture.

Authors:  Victoria L King; Alexander Y Lin; Fjoralba Kristo; Thomas J T Anderson; Neil Ahluwalia; Gregory J Hardy; A Phillip Owens; Deborah A Howatt; Dongxiao Shen; Andrew M Tager; Andrew D Luster; Alan Daugherty; Robert E Gerszten
Journal:  Circulation       Date:  2009-01-12       Impact factor: 29.690

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.